Tuomo Alanko, MD, PhD, is specialized in treating cancers of the GI tract, such as cancers of the bowel, stomach, pancreas and liver. He is the current Chairman of the Executive Board of Colores – Finnish Colorectal Cancer Patient Association.

Timo Joensuu, MD, PhD, Adjunct Professor, is an expert in prostate cancer and specialises in its drug treatment and radiotherapy. He was the first in Finland and in the Nordic countries to employ IMRT treatment and the most advanced VMAT RapidArc and HDR brachytherapies. The Cancer Society of Finland awarded him a medal for fighting cancer in 2006, and in 2010 he was chosen as the Influencer of the Year in the field of healthcare.

Jukka Kemppainen, MD, PhD, Adjunct Professor, is focused on the clinical applications of PET imaging in disease diagnostics. His main interests reside in the development of new PET imaging tracers for prostate cancer and PET diagnostics.

Mika Matikainen, MD, PhD, is an Associate Professor in Urology and Chief of the Department of Urology at HUS Helsinki University Hospital. He is specialized in urological cancers including prostate cancer diagnostics, surgical and medical treatment of prostate cancer and robotic assisted laparoscopic radical prostatectomy (RALP).

Mika Niemelä, MD, PhD, is a Professor of Neurosurgery, Head of HUS Helsinki University Hospital Neurosurgery department and Head of Neurosurgery Research Group at Biomedicum Helsinki. He has written 212 publications and 9 international book chapters on cerebrovascular diseases, brain tumors, aneurysm wall and genetics of intracranial aneurysms. His interests include vascular, skull base and brain tumors as well as spine.

Tom Wiklund, MD, PhD, Adjunct Professor, is specialized in sarcoma, lymphoma and breast and testicular cancer. The highlight of Wiklund’s clinical career has been setting up and leading a unit specializing in blood stem cell replacement therapy at Helsinki University Central Hospital.